Abstract
In the original version of this article (1), Fig. 4E was missing splice lines at p50 and p52, between TNFa and PBS-1086, and consequently the Nucleolin panel did not line up with the other two blots. These errors have been corrected in the latest online HTML and PDF versions of the article. The authors regret these errors. Reference 1. Fabre C, Mimura N, Bobb K, Kong SY, Gorgun G, Cirstea D, et al. Dual inhibition of canonical and noncanonical NF-kB pathways demonstrates significant antitumor activities in multiple myeloma. Clin Cancer Res 2012;18:4669–81.
| Original language | English (US) |
|---|---|
| Number of pages | 1 |
| Journal | Clinical Cancer Research |
| Volume | 25 |
| Issue number | 9 |
| DOIs |
|
| State | Published - Sep 1 2012 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Oncology
- Cancer Research
Cite this
Erratum : Dual inhibition of canonical and noncanonical NF-kB pathways demonstrates significant antitumor activities in multiple myeloma (Clin Cancer Res (2019) 18(4669–81)Doi:10.1158/1078-0432.CCR-12-0779). / Fabre, Claire; Mimura, Naoya; Bobb, Kathryn; Kong, Sun Young; Gorgun, Gullu; Cirstea, Diana; Hu, Yiguo; Minami, Jiro; Ohguchi, Hiroto; Zhang, Jie; Meshulam, Jeffrey; Carrasco, Ruben D.; Tai, Yu Tzu; Richardson, Paul G.; Hideshima, Teru; Anderson, Kenneth C.
In: Clinical Cancer Research, Vol. 25, No. 9, 01.09.2012.Research output: Contribution to journal › Comment/debate
}
TY - JOUR
T1 - Erratum
T2 - Dual inhibition of canonical and noncanonical NF-kB pathways demonstrates significant antitumor activities in multiple myeloma (Clin Cancer Res (2019) 18(4669–81)Doi:10.1158/1078-0432.CCR-12-0779)
AU - Fabre, Claire
AU - Mimura, Naoya
AU - Bobb, Kathryn
AU - Kong, Sun Young
AU - Gorgun, Gullu
AU - Cirstea, Diana
AU - Hu, Yiguo
AU - Minami, Jiro
AU - Ohguchi, Hiroto
AU - Zhang, Jie
AU - Meshulam, Jeffrey
AU - Carrasco, Ruben D.
AU - Tai, Yu Tzu
AU - Richardson, Paul G.
AU - Hideshima, Teru
AU - Anderson, Kenneth C.
PY - 2012/9/1
Y1 - 2012/9/1
N2 - In the original version of this article (1), Fig. 4E was missing splice lines at p50 and p52, between TNFa and PBS-1086, and consequently the Nucleolin panel did not line up with the other two blots. These errors have been corrected in the latest online HTML and PDF versions of the article. The authors regret these errors. Reference 1. Fabre C, Mimura N, Bobb K, Kong SY, Gorgun G, Cirstea D, et al. Dual inhibition of canonical and noncanonical NF-kB pathways demonstrates significant antitumor activities in multiple myeloma. Clin Cancer Res 2012;18:4669–81.
AB - In the original version of this article (1), Fig. 4E was missing splice lines at p50 and p52, between TNFa and PBS-1086, and consequently the Nucleolin panel did not line up with the other two blots. These errors have been corrected in the latest online HTML and PDF versions of the article. The authors regret these errors. Reference 1. Fabre C, Mimura N, Bobb K, Kong SY, Gorgun G, Cirstea D, et al. Dual inhibition of canonical and noncanonical NF-kB pathways demonstrates significant antitumor activities in multiple myeloma. Clin Cancer Res 2012;18:4669–81.
UR - http://www.scopus.com/inward/record.url?scp=85065553128&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85065553128&partnerID=8YFLogxK
U2 - 10.1158/1078-0432.CCR-19-0959
DO - 10.1158/1078-0432.CCR-19-0959
M3 - Comment/debate
C2 - 31043386
AN - SCOPUS:85065553128
VL - 25
JO - Clinical Cancer Research
JF - Clinical Cancer Research
SN - 1078-0432
IS - 9
ER -